retatrutide ly3437943 triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide is a triple-agonist drug

For some patients, a GLP-1 or related medication may be appropriate

Common GLP-1 agonists include: Semaglutide (brand names like Wegovy, Ozempic) Liraglutide (Saxenda, Victoza) Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) is actually a GLP1/GIP agonist

A vendor selling 98% purity retatrutide who provides an HPLC chromatogram, mass spectrometry data, and batch-specific testing results is operating at a fundamentally different level than one who simply prints "98% purity" on a label

Filed Under: Biologics, Endocrinology

Use only the diluent named by the manufacturer or dispensing pharmacy

Though many peptides occur naturally in our bodies, others do not